share_log

Evelo Biosciences | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)

SEC announcement ·  Jan 27 06:36
Summary by Futu AI
Evelo Biosciences, Inc. has officially filed a Form 15 with the United States Securities and Exchange Commission (SEC) to terminate its registration under Section 12(g) of the Securities Exchange Act of 1934, as well as to suspend its duty to file reports under Sections 13 and 15(d) of the same act. The filing indicates that Evelo Biosciences will no longer be required to file periodic financial reports with the SEC. The decision to deregister was made under Rule 12g-4(a)(1) and Rule 15d-6, as marked on the form. The company reported approximately 36 holders of record as of the notice date. The certification was signed by Craig R. Jalbert, the Chief Executive Officer, President, and Director of Evelo Biosciences, on January 26, 2024.
Evelo Biosciences, Inc. has officially filed a Form 15 with the United States Securities and Exchange Commission (SEC) to terminate its registration under Section 12(g) of the Securities Exchange Act of 1934, as well as to suspend its duty to file reports under Sections 13 and 15(d) of the same act. The filing indicates that Evelo Biosciences will no longer be required to file periodic financial reports with the SEC. The decision to deregister was made under Rule 12g-4(a)(1) and Rule 15d-6, as marked on the form. The company reported approximately 36 holders of record as of the notice date. The certification was signed by Craig R. Jalbert, the Chief Executive Officer, President, and Director of Evelo Biosciences, on January 26, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.